Biodefense Market Industry Trends, Estimation & Forecast, 2018-2025

Significant funding by the U.S. civilian and military organizations, such as Centers for Disease Control and Prevention (CDC), The United States Department of Health & Human Services (HHS), and The Department of Defense (DoD), is also boosting the market growth. Rising prevalence of infectious diseases, such as influenza, is estimated to be one of the key factors boosting the investments for biological threats. In U.S., the federal agency has allocated a considerable budget targeting various biodefense and non-biodefense goals and applications, which are mainly intended to deal with a range of healthcare, public health, national security, and international security issues. These programs conduct scientific research of infectious diseases, create awareness, and improve public health preparedness.

Rising government initiatives aimed at enhancing the preparedness against Chemical, Biological, Radiological and Nuclear (CBRN) threats is a key factor driving the market. Increased adoption of technologies, such as gene chips for pathogen detection in forensic division, nanotechnology, data base management systems, and advanced detector hardware in biodefense-related drug development is projected to drive the market further.

Moreover, growing prevalence of congenital Zika virus infection is likely to boost the investments in the field of biodefense. Nuclear or radiation weapons cause destruction due to the harmful effects of ionizing radiation and render damage similar to explosive bombs. CBRN and explosives constitute Weapons of Mass Destruction (WMD) that have the potential to cause annihilation of high magnitude. To mitigate the risk, governments of various countries are actively funding for medical countermeasures against such threats, thereby, positively impacting the global market.

The global biodefense market size was valued at USD 5.47 billion in 2018 and is anticipated to expand at a CAGR of 4.5 % over the forecast period. 

To request a sample copy or view summary of this report, click the link below:
https://www.digitsnmarkets.com/sample/4215-biodefense-market

Worldwide biosensor market is segmented on the basis of type, product, application, and region. The Biodefense market is segmented into sensor patch, embedded device. Further it is classified as wearable and non wearable segments, home diagnostics, point of care, bio-defence and research lab, and food and beverages among others. which has a prominent shares in this market.

Global market size of Bio defense in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bio defense in these regions.

Competitors identified in this market include among others, Achaogen, Inc.; Alexeter Technologies, LLC; Alnylam Pharmaceuticals, Inc.; Altimmune, Inc.; ANP Technologies, Inc.; Bavarian Nordic A/S; Cleveland BioLabs, Inc.; Elusys Therapeutics, Inc.; Emergent BioSolutions, Inc.; Ichor Medical Systems, Inc.; New Horizons Diagnostic Corporation; PathSensors, Inc.; Research International, Inc.; SIGA Technologies

Contact Us :
Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: sales@digitsnmarkets.com
Website:- www.digitsnmarkets.com

About Digits N Markets:
Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

This release was published on openPR.